The nation of Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (£272m) over five years due to the United States' insistence on sensitive biological samples.
The decision was revealed following a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesperson later explained that the United States was requesting genetic material for scientific study and profit while refused to guarantee the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further dialogue to secure a deal agreeable to both sides so the country's critical HIV programme can proceed.
Wider Implications
This rejection follows a comparable situation in Kenya, where a court suspended a similar health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to boost openness and accountability.
As per statements, 16 nations in Africa have to date agreed to similar agreements, representing more than $18.3bn in committed funds.
Details of the Declined Deal
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our nation would supply the basic resources for medical research without any certainty that the final treatments would be accessible to our population should a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of bilateral deals were undermining frameworks already established through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with potential pandemics.
"This framework is designed to guarantee that when a nation provides its samples, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to develop them."
These objections over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage ongoing discussions with our American counterparts on how future collaboration could be arranged in a manner that honours the independence and interests of each country."
Medical Community Response
Medical experts said it understood the official position, but suggested that negotiations must proceed given that a large portion of the nation's Aids initiatives depended on international support.
"Where technical issues exist, such as those involving data governance or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group said.
The halted deal highlights the ongoing tensions between receiving crucial international aid and protecting local interests in an ever more interconnected world.